Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2013 Jun 10;13(5):559–567. doi: 10.1016/j.clml.2013.03.019

Table 5.

Best clinical response (as assessed by study investigators)

Barasertib dose + LDAC 400 mg

Response, n (%) 800 mg
(n=6)
1000 mg
(n=13)
1200 mg
(n=3)
CR 2 3 1
CRi 0 2 0
PR 1 1 0
ORR 3 (50) 6 (46) 1 (33)

CR, complete response; CRi, complete response with incomplete recovery of neutrophils and/or platelets; PR, partial response; ORR, overall response rate